Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

AmCad BioMed Corporation (4188) Financial Statements

AmCad BioMed Corporation Financial Overview

AmCad BioMed Corporation's market cap is currently NT$867.66M. The company's EPS TTM is NT$-0.83; its P/E ratio is -16.51; AmCad BioMed Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 30.44MNT$ 53.10MNT$ 65.26MNT$ 61.63MNT$ 85.79M
Gross ProfitNT$ 10.02MNT$ 32.93MNT$ 41.02MNT$ 38.05MNT$ 60.66M
Operating IncomeNT$ -87.95MNT$ -64.66MNT$ -53.98MNT$ -54.28MNT$ -26.84M
EBITDANT$ -55.52MNT$ -34.41MNT$ -25.56MNT$ -36.60MNT$ -8.46M
Net IncomeNT$ -55.72MNT$ -50.58MNT$ -45.31MNT$ -53.49MNT$ -25.54M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 371.22MNT$ 365.71MNT$ 287.27MNT$ 330.84MNT$ 371.05M
Total AssetsNT$ 622.70MNT$ 694.87MNT$ 512.65MNT$ 553.86MNT$ 615.75M
Total DebtNT$ 4.75MNT$ 10.87MNT$ 14.50MNT$ 10.49MNT$ 14.80M
Net DebtNT$ -19.85MNT$ -6.88MNT$ -15.16MNT$ -36.55MNT$ -43.71M
Total LiabilitiesNT$ 21.88MNT$ 31.16MNT$ 34.70MNT$ 34.08MNT$ 36.72M
Stockholders' EquityNT$ 521.42MNT$ 568.65MNT$ 380.58MNT$ 424.58MNT$ 482.98M
Cash Flow
Free Cash FlowNT$ -47.44MNT$ -54.90MNT$ -41.89MNT$ -34.81MNT$ -41.30M
Operating Cash FlowNT$ -47.06MNT$ -51.85MNT$ -41.60MNT$ -34.19MNT$ -38.97M
Investing Cash FlowNT$ 58.93MNT$ -185.43MNT$ 27.31MNT$ 27.14MNT$ 49.18M
Financing Cash FlowNT$ -5.02MNT$ 225.38MNT$ -3.10MNT$ -4.42MNT$ -11.35M

Currency in TWD

AmCad BioMed Corporation Earnings and Revenue History

-80M080M160M-240 %-160 %-80 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

AmCad BioMed Corporation Liabilities to Assets

0250M500M750M2.5 %5 %7.5 %10 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

AmCad BioMed Corporation Cash Flow

-300M-200M-100M0100M200M300M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

AmCad BioMed Corporation Forecast EPS vs Actual EPS

-0.2-0.2-0.2-0.2-0.1-0.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >